Russell J. Cox's Net Worth
$20.5 Million
Who is Russell J. Cox?
Russell J. Cox has an estimated net worth of $20.5 Million. This is based on reported shares across multiple companies, which include VITAL THERAPIES INC, Gossamer Bio, Inc., Jazz Pharmaceuticals plc, and Aeglea BioTherapeutics, Inc..
SEC CIK
Russell J. Cox's CIK is 0001512984
Past Insider Trading and Trends
2012 was Russell J. Cox's most active year for acquiring shares with 7 total transactions. Russell J. Cox's most active month to acquire stocks was the month of May. 2012 was Russell J. Cox's most active year for disposing of shares, totalling 8 transactions. Russell J. Cox's most active month to dispose stocks was the month of July. 2012 saw Russell J. Cox paying a total of $1,235,198.23 for 225,012 shares, this is the most they've acquired in one year. In 2012 Russell J. Cox cashed out on 166,015 shares for a total of $2,332,686.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VITAL THERAPIES INC (IMUX) Snapshot price: $1.22
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 7.2K |
$16.00 | $115,200.00 | 7.2K |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.215
EVP & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +97.49% | 50.76K |
$13.63 | $691,676.44 | 102.82K |
Dec 11
| |||
Form 4
| -1.85% | -978.00 |
$155.56 | -$152,137.68 | 51.98K |
Aug 7
| |||
Form 4
| -3.28% | -1.79K |
$132.81 | -$238,128.33 | 52.8K |
Mar 6
| |||
Form 4
| +22.43% | 10K |
—
|
—
| 54.59K |
Mar 2
| |||
Form 4
| -5.32% | -2.51K |
$136.97 | -$343,383.79 | 44.59K |
Feb 27
| |||
Form 4
| -7.83% | -4.00K |
$128.75 | -$515,000.00 | 47.09K |
Scheduled
|
Jan 18
| ||
Form 4
| -15.75% | -9.54K |
$149.34 | -$1,425,177.21 | 51.04K |
Scheduled
|
Aug 7 - Aug 9
| ||
Form 4
| -6.20% | -4.00K |
$136.98 | -$547,920.00 | 60.47K |
Scheduled
|
Apr 12
| ||
Form 4
| -2.35% | -1.55K |
$127.84 | -$198,152.00 | 64.47K |
Mar 7
| |||
Form 4
| -1.40% | -939.00 |
$121.58 | -$114,163.62 | 66.02K |
Feb 29
| |||
Form 4
| +14.09% | 8.27K |
$125.00 | -$91,375.00 | 66.96K |
Feb 25 - Feb 26
| |||
Form 4
| -0.85% | -500.00 |
$177.82 | -$88,910.00 | 58.6K |
Scheduled
|
Aug 11
| ||
Form 4
| -8.57% | -5.54K |
$181.53 | -$1,006,246.82 | 59.1K |
Aug 7 - Aug 10
| |||
Form 4
| -0.77% | -500.00 |
$181.45 | -$90,725.00 | 64.55K |
Scheduled
|
Apr 14
| ||
Form 4
| -3.09% | -2.07K |
$174.84 | -$362,097.96 | 65.05K |
Mar 5
| |||
Form 4
| +11.14% | 6.73K |
$170.09 | -$161,245.32 | 67.12K |
Feb 26 - Feb 27
| |||
Form 4
| -6.93% | -4.47K |
$133.86 | -$598,755.78 | 60.06K |
Aug 11
| |||
Form 4
| +13.15% | 7.5K |
—
|
—
| 64.53K |
Aug 7
| |||
Form 4
| -3.39% | -2.00K |
$155.00 | -$310,000.00 | 57.03K |
Scheduled
|
Jun 20
| ||
Form 4
| -2.15% | -1.29K |
$157.60 | -$203,461.60 | 58.73K |
Mar 5
| |||
Form 4
| +11.11% | 6K |
$164.59 | -$658,360.00 | 60.02K |
Feb 27
| |||
Form 4
| -1.86% | -1.00K |
$88.16 | -$88,160.00 | 52.74K |
Scheduled
|
Sep 4
| ||
Form 4
| -5.80% | -3.31K |
$80.88 | -$267,712.80 | 53.74K |
Aug 9
| |||
Form 4
| -3.39% | -2.00K |
$76.22 | -$152,440.00 | 57.05K |
Scheduled
|
Aug 1
| ||
Form 4
| -1.67% | -1.00K |
$58.54 | -$58,540.00 | 58.77K |
Scheduled
|
May 20
| ||
Form 4
| +29.88% | 13.75K |
—
|
—
| 59.77K |
Mar 5
| |||
Form 4
| -10.00% | -5.00K |
$57.24 | -$286,200.00 | 45.01K |
Scheduled
|
Oct 1
| ||
Form 4
| +233.15% | 35K |
—
|
—
| 50.01K |
Aug 9
| |||
Form 4
| +7.19% | 1.01K |
$14.89 | $14,994.23 | 15.01K |
May 31
| |||
Form 4
| -26.31% | -5.00K |
$49.56 | -$247,800.00 | 14.01K |
Mar 9
| |||
Form 4
|
∞
| 19K |
—
|
—
| 19K |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -19.00K |
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +1,464.20% | 17.79K |
$35.44 | -$578,482.00 | 19K |
Jan 11
| |||
Form 4
| +484.13% | 1.01K |
$14.89 | $14,994.23 | 1.22K |
Nov 30
| |||
Form 4
|
∞
| 208 |
$14.89 | $3,097.12 | 208 |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
∞
| 7K |
$10.00 | $70,000.00 | 7K |
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||